Loading song details...
Satellos Bioscience MSCL Encouraging Phase 1b Trial Data Adults With Duchenne Muscular Dystrophy
No description available.
MP3 Download
Video Download
Related Songs
1:23:15
Satellos Bioscience MSCL Encouraging Phase 1b Trial Data Adults With Duchenne Muscular Dystrophy
13:26
Satellos Bioscience MSCL Chief Technology Officer Phil Lambert Discusses SAT 3153 Study Results
1:01:44
Satellos Bioscience MSCL CEO Frank Gleeson CMO Dr Wildon Farwell Trial Update Catalysts
1:06:58
Satellos MSCL Presentation Deep Dive And Q A With CEO Frank Gleeson
48:03
Satellos Bioscience MSCL CEO Frank Gleeson CTO Phil Lambert Deep Dive Review Outlook
2:53
Satellos Bioscience Aims To Advance The Clinical Development Of Medicine Related Muscle Disorders
0:20
Satellos Virtually Opens The Market September 28 2021
9:20
Phil Lambert Ph D Chief Scientific Officer Satellos Bioscience Inc Part 1
1:02:56
Satellos Bioscience MSCL CEO Frank Gleeson Phase 1 2 Milestones For 2024 2025 Targeting DMD
1:11:15
Satellos CEO On Breakthrough Duchenne Drug Early Trial Results Molecules And Minerals
1:20
Satellos Bioscience Inc TSX MSCL 2024 Venture 50
49:41
Satellos CEO Frank Gleeson On SAT 3247 Interim Trial Updates And Upcoming Catalysts
2:46
Phil Lambert Ph D Chief Scientific Officer Satellos Bioscience Part 3
51:43
Satellos MSCL CEO Frank Gleeson CFO Liz Williams Product Development And Milestones
0:21
Satellos Bioscience Inc Opens The Market Wednesday May 15 2024
8:13
Satellos BioScience Files Patents As Company Looks To Help In The Treatment Of Duchenne
1:49
Phil Lambert Ph D Chief Scientific Officer Satellos Bioscience Inc Part 2
23:57
New Ways To Treat Duchenne Muscular Dystrophy
1:22:16
Defeat Duchenne Canada 2022 Family Forum Session 1 Research And Drug Development Updates
45:32